在肺腺癌中使用 pembrolizumab 治疗后的高进行性疾病 : 尸检病例研究。
关键词: ALK, anaplastic lymphoma kinase DIC, Disseminated intravascular coagulation DVT, deep vein thrombosis EBUS-TBNA, Endobronchial ultrasound-transbronchial needle aspiration ECOG, Eastern Cooperative Oncology Group EGFR, epidermal growth factor receptor HPD, hyperprogressive disease HRCT, high-resolution computed tomography Hyperprogressive disease ILD, Interstitial lung disease Immune checkpoint inhibitors NSCLC, non-small cell lung cancer Non-small cell lung cancer PD-L1 PD-L1, Programmed cell death ligand 1
来 源:
DOI:10.1016/j.rmcr.2019.100885
PDF(Sci-hub)
PDF(Pubmed)